After years of successfully fortifying our local presence, Elixir is looking to become a strong member of the regional pharmaceuticals market in this next stage.

We are on a steady trajectory toward establishing ourselves among the 50 leading pharmaceutical companies in the region and expanding into exports by launching our exports arm, both of which are goals we aim to accomplish by 2023.

In addition, our short-term plan encompasses inaugurating our production facility, which should be fully operational by 2025.

Through these efforts we will continue to diversify our brands to satisfy market demands; acquire new talents in line with our growing capacities; increase the reach of our offerings to neighboring states; and position ourselves among the top pharmaceutical exporters to African countries.